Cargando…

Patient-reported outcomes in randomised clinical trials of bladder cancer: an updated systematic review

BACKGROUND: Despite international recommendations of including patient-reported outcomes (PROs) in randomised clinical trials (RCTs), a 2014 review concluded that few RCTs of bladder cancer (BC) report PRO as an outcome. We therefore aimed to update the 2014 review to synthesise current evidence-bas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Van Hemelrijck, Mieke, Sparano, Francesco, Josephs, Debra, Sprangers, Mirjam, Cottone, Francesco, Efficace, Fabio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6744649/ https://www.ncbi.nlm.nih.gov/pubmed/31521149 http://dx.doi.org/10.1186/s12894-019-0518-9

Ejemplares similares

Harnessing the patient voice in prostate cancer research: Systematic review on the use of patient‐reported outcomes in randomized controlled trials to support clinical decision‐making
por: Van Hemelrijck, Mieke, et al.
Publicado: (2020)

Investigating the impact of open label design on patient‐reported outcome results in prostate cancer randomized controlled trials
por: Mouillet, Guillaume, et al.
Publicado: (2020)

Evaluating methodological quality of Prognostic models Including Patient-reported HeAlth outcomes iN oncologY (EPIPHANY): a systematic review protocol
por: Deliu, Nina, et al.
Publicado: (2018)

The prognostic value of patient-reported outcomes in allogeneic hematopoietic stem cell transplantation: exploratory analysis of a randomized nutrition intervention trial
por: Gudmundstuen, Anne Marte, et al.
Publicado: (2023)

Association Between Vitamin D and Novel SARS-CoV-2 Respiratory Dysfunction – A Scoping Review of Current Evidence and Its Implication for COVID-19 Pandemic
por: Santaolalla, Aida, et al.
Publicado: (2020)

Graham Roberts Study protocol: first ‘trials within cohort study’ for bladder cancer
por: Wylie, Harriet, et al.
Publicado: (2019)

Chimeric Antigen Receptor T-cell Therapy in Hematologic Malignancies and Patient-reported Outcomes: A Scoping Review
por: Efficace, Fabio, et al.
Publicado: (2022)

Distribution- and anchor-based methods to determine the minimally important difference on patient-reported outcome questionnaires in oncology: a structured review
por: Ousmen, Ahmad, et al.
Publicado: (2018)

The GIMEMA-ALLIANCE Digital Health Platform for Patients With Hematologic Malignancies in the COVID-19 Pandemic and Postpandemic Era: Protocol for a Multicenter, Prospective, Observational Study
por: Efficace, Fabio, et al.
Publicado: (2021)

Expectant management in genitourinary malignancies (prostate, bladder, kidney)
por: Van Hemelrijck, Mieke, et al.
Publicado: (2021)

Health-Related Quality of Life Assessment in Patients with Myelodysplastic Syndromes: Evidence from Randomized Clinical Trials
por: Giesinger, Johannes M., et al.
Publicado: (2021)

Physicians’ attitude towards selection of second line therapy with nilotinib and dasatinib in chronic myeloid leukemia patients
por: Breccia, Massimo, et al.
Publicado: (2017)

Cohort profile: King’s Health Partners bladder cancer biobank
por: Kotecha, Pinky, et al.
Publicado: (2020)

Editorial: Bladder Cancer – A Cinderella Cancer: Advances and Remaining Research Questions
por: Van Hemelrijck, Mieke, et al.
Publicado: (2020)

Chronic inflammatory diseases, anti-inflammatory medications and risk of prostate cancer: a population-based case-control study
por: Beckmann, Kerri, et al.
Publicado: (2019)

Association between serum markers of the humoral immune system and inflammation in the Swedish AMORIS study
por: Santaolalla, Aida, et al.
Publicado: (2021)

Systematic review of the association between socioeconomic status and bladder cancer survival with hospital type, comorbidities, and treatment delay as mediators
por: Russell, Beth, et al.
Publicado: (2021)

The CONSORT Patient-Reported Outcome (PRO) extension: implications for clinical trials and practice
por: Calvert, Melanie, et al.
Publicado: (2013)

Female sexual function in bladder cancer: A review of the evidence
por: Martin, Rebecca, et al.
Publicado: (2022)

Phase III randomised chemoprevention study of Selenium on the recurrence of non-invasive bladder cancer. The SELEnium and BLAdder cancer Trial (SELEBLAT)
por: Goossens, Maria (Mieke), et al.
Publicado: (2015)

Cohort Profile Update: The National Prostate Cancer Register of Sweden and Prostate Cancer data Base—a refined prostate cancer trajectory
por: Van Hemelrijck, Mieke, et al.
Publicado: (2016)

Risk of in-hospital complications after radical cystectomy for urinary bladder carcinoma: population-based follow-up study of 7608 patients
por: Hemelrijck, Mieke, et al.
Publicado: (2013)

Chronic inflammation markers are associated with risk of pancreatic cancer in the Swedish AMORIS cohort study
por: Sollie, Sam, et al.
Publicado: (2019)

Impact of age on the toxicity of immune checkpoint inhibition
por: Samani, Amit, et al.
Publicado: (2020)

Serum Immunoglobulin G Is Associated With Decreased Risk of Pancreatic Cancer in the Swedish AMORIS Study
por: Sollie, Sam, et al.
Publicado: (2020)

CanWalk: a feasibility study with embedded randomised controlled trial pilot of a walking intervention for people with recurrent or metastatic cancer
por: Tsianakas, Vicki, et al.
Publicado: (2017)

Infliximab to treat Crohn’s disease: an update
por: Cottone, M, et al.
Publicado: (2011)

A mediation analysis to explain socio‐economic differences in bladder cancer survival
por: Russell, Beth, et al.
Publicado: (2020)

Global incidence and outcome of testicular cancer
por: Shanmugalingam, Thurkaa, et al.
Publicado: (2013)

Raising the standards of patient‐centered outcomes research in myelodysplastic syndromes: Clinical utility and validation of the subscales of the QUALMS from the MDS‐RIGHT project
por: Efficace, Fabio, et al.
Publicado: (2022)

Outcomes in Hybrid Breast Reconstruction: A Systematic Review
por: Alessandri Bonetti, Mario, et al.
Publicado: (2022)

Laparoscopic radical prostatectomy outcome data: how should surgeon’s performance be reported? A retrospective learning curve analysis of two surgeons
por: Mason, Sarah, et al.
Publicado: (2016)

Systematic Evaluation of Patient-Reported Outcome Protocol Content and Reporting in Cancer Trials
por: Kyte, Derek, et al.
Publicado: (2019)

A prospective observational study to assess clinical decision-making, prognosis, quality of life and satisfaction with care in patients with relapsed/refractory multiple myeloma: the CLARITY study protocol
por: Efficace, Fabio, et al.
Publicado: (2018)

Reporting of adverse events associated with spinal manipulation in randomised clinical trials: an updated systematic review
por: Gorrell, Lindsay M, et al.
Publicado: (2023)

Overcoming barriers to the implementation of patient-reported outcomes in cancer clinical trials: the PROMOTION Registry
por: Efficace, Fabio, et al.
Publicado: (2014)

Your next clinical cancer research project: preparation in a multidisciplinary environment is key
por: Van Hemelrijck, Mieke, et al.
Publicado: (2017)

The need for research methodology to improve acceptability of long-term surveillance for cancer
por: Kinsella, Netty, et al.
Publicado: (2021)

Immune mediator expression signatures are associated with improved outcome in ovarian carcinoma
por: Nakamura, Mano, et al.
Publicado: (2019)

Cord pilot trial: update to randomised trial protocol
por: Bradshaw, Lucy E., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ia410ftpek1ptoe41069tkfaps